Department of Surgery, Kaohsiung Veterans General Hospital Pingtung Branch, Pingtung, Taiwan.
Nutrition. 2012 May;28(5):559-65. doi: 10.1016/j.nut.2011.09.008. Epub 2012 Jan 20.
Conjugated linoleic acid (CLA) has several benefits, including body fat reduction, as proved in animals. However, the results of CLA-induced body composition alterations in humans are inconsistent, and no related data are available for Chinese populations. This study aimed to determine whether CLA affects body weight (BW) loss and body composition of overweight and obese Chinese subjects.
In this randomized, double-blind, placebo-controlled trial, subjects with a body mass index (BMI) of 24 to 35 kg/m(2) randomly received 1.7 g of cis-9,trans-11 and trans-10,cis-12 CLA (n = 30) or placebo (salad oil; n = 33) in 200 mL of sterilized milk twice daily for 12 wk. Changes in body composition were determined by bioimpedance measurements.
Sixty-three subjects completed the study (CLA, n = 30). After 12 wk, compared with the baseline, the BW, BMI, total fat mass, fat percentage, subcutaneous fat mass, and waist-to-hip ratio decreased in the CLA group (P < 0.05). The CLA group was stratified by BMI and gender. The BW, BMI, subcutaneous fat mass, and waist-to-hip ratio decreased in 27 subjects with a BMI ≥ 27, and these indices, except subcutaneous fat mass, were lower in female subjects. The levels of total cholesterol, triacylglycerol, low-density lipoprotein, and plasma fasting glucose increased, whereas those of high-density lipoprotein decreased after 3 mo of CLA treatment. The changes were not significantly different from the baseline values.
The supplementation of CLA for 12 wk in overweight and grade I obese Chinese subjects yielded lower obesity indices, with no obvious adverse effects.
共轭亚油酸(CLA)具有多种益处,包括减少体脂肪,这已在动物身上得到证实。然而,CLA 诱导人体身体成分改变的结果并不一致,并且针对中国人群尚无相关数据。本研究旨在确定 CLA 是否会影响超重和肥胖的中国受试者的体重(BW)减轻和身体成分。
在这项随机、双盲、安慰剂对照试验中,BMI 为 24 至 35 kg/m²的受试者随机接受 1.7 g 的顺式-9,反式-11 和反式-10,顺式-12 CLA(n = 30)或安慰剂(色拉油;n = 33),每天两次,每次 200 mL,在消毒牛奶中服用 12 周。通过生物阻抗测量确定身体成分的变化。
63 名受试者完成了研究(CLA 组,n = 30)。与基线相比,12 周后,CLA 组的 BW、BMI、总脂肪量、脂肪百分比、皮下脂肪量和腰臀比降低(P < 0.05)。CLA 组按 BMI 和性别分层。27 名 BMI≥27 的受试者的 BW、BMI、皮下脂肪量和腰臀比降低,除了皮下脂肪量外,女性受试者的这些指数也降低。3 个月的 CLA 治疗后,总胆固醇、三酰甘油、低密度脂蛋白和血浆空腹血糖水平升高,而高密度脂蛋白水平降低。这些变化与基线值无明显差异。
在超重和 I 级肥胖的中国受试者中补充 CLA 12 周可降低肥胖指数,且无明显不良反应。